Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devendra C Desai

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
JOP : Journal of the Pancreas|July 6, 2010
Choledochal cysts with chronic pancreatitis in adults: report of two cases with a review of the literatureBiswanath P Gouda, Devendra C Desai, Philip Abraham, et al.
Drug Metabolism and Personalized Therapy|February 23, 2018
Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicitySwarup A V Shah, Minal U Paradkar, Devendra C Desai, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 12, 2011
Comparison of Mycobacterium tuberculosis culture using liquid culture medium and Lowenstein Jensen medium in abdominal tuberculosisSudeep R Shah, Shubhada Shenai, Devendra C Desai, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|September 3, 2013
Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significanceSandeep Kirit Davavala, Devendra C Desai, Philip Abraham, et al.
European Journal of Clinical Pharmacology|August 18, 2020
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experienceMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
European Journal of Clinical Pharmacology|September 5, 2020
Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experienceMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
Nephrology (Carlton, Vic.)|March 5, 2004
Acute renal tubular injury with acute hepatitis A infection: is it just a coincidence?Gautam R Shroff, SunilL V Badve, Anand G Joshi, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 2, 2009
An Indian family of multiple endocrine neoplasia type 1 (MEN1): molecular diagnosis, treatment and follow upSudeep R Shah, Rani Raghavan, Devendra C Desai, et al.
Annals of Hepatology|March 15, 2006
Hepatic tuberculosis in absence of disseminated abdominal tuberculosisChirag S Desai, Anand G Josh, Philip Abraham, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 16, 2020
Correction to: Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An auditMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JOP : Journal of the Pancreas|July 6, 2010
Choledochal cysts with chronic pancreatitis in adults: report of two cases with a review of the literatureBiswanath P Gouda, Devendra C Desai, Philip Abraham, et al.
Drug Metabolism and Personalized Therapy|February 23, 2018
Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicitySwarup A V Shah, Minal U Paradkar, Devendra C Desai, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 12, 2011
Comparison of Mycobacterium tuberculosis culture using liquid culture medium and Lowenstein Jensen medium in abdominal tuberculosisSudeep R Shah, Shubhada Shenai, Devendra C Desai, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|September 3, 2013
Prevalence of TPMT polymorphism in Indian patients requiring immunomodulator therapy and its clinical significanceSandeep Kirit Davavala, Devendra C Desai, Philip Abraham, et al.
European Journal of Clinical Pharmacology|August 18, 2020
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experienceMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
European Journal of Clinical Pharmacology|September 5, 2020
Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experienceMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
Nephrology (Carlton, Vic.)|March 5, 2004
Acute renal tubular injury with acute hepatitis A infection: is it just a coincidence?Gautam R Shroff, SunilL V Badve, Anand G Joshi, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|May 2, 2009
An Indian family of multiple endocrine neoplasia type 1 (MEN1): molecular diagnosis, treatment and follow upSudeep R Shah, Rani Raghavan, Devendra C Desai, et al.
Annals of Hepatology|March 15, 2006
Hepatic tuberculosis in absence of disseminated abdominal tuberculosisChirag S Desai, Anand G Josh, Philip Abraham, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 16, 2020
Correction to: Clinical efficacy of infliximab level and anti-infliximab antibody measurement in patients with inflammatory bowel disease: An auditMihika B Dave, Alpa J Dherai, Devendra C Desai, et al.
Pageof 3